Freeze-Dried Watermelon Supplementation Has Modest Effects on Bone and Lipid Parameters of Ovariectomized Mice.

dyslipidemia estrogen deficiency menopause osteoporosis watermelon

Journal

Preventive nutrition and food science
ISSN: 2287-1098
Titre abrégé: Prev Nutr Food Sci
Pays: Korea (South)
ID NLM: 101586663

Informations de publication

Date de publication:
31 Mar 2020
Historique:
received: 26 09 2019
accepted: 17 01 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 16 4 2020
Statut: ppublish

Résumé

This study investigated the effects of two doses of freeze-dried watermelon (WM) on bone and lipid parameters in ovariectomized (OVX) mice, a model of post-menopausal osteoporosis. Three-month-old C57BL/6 female mice (n=46) were sham-operated (SHAM) or OVX and randomly assigned to the control or WM diets for 12 weeks: SHAM-control, OVX-control, OVX+1%, or 10% (wt/wt) freeze-dried WM. All diets were isocaloric and isonitrogenous, and had the same calcium and phosphorus concentrations. Freeze-dried WM supplementation was not able to prevent the decrease in whole body, tibial, and lumbar bone mineral density due to estrogen deficiency. Micro-computed tomography analyses showed that WM was also not able to modulate changes in tibial trabecular and cortical bone microarchitecture due to ovariectomy. However, the lumbar trabecular micro-architecture analyses revealed that the WM-10% group had a similar connectivity density, trabecular number, trabecular separation, and structure model index as the SHAM group. Supplementation with 10% WM reduced plasma cholesterol and total liver lipids to the level of the SHAM group but was still similar to that of the OVX-control group. Supplementation with 10% WM increased liver catalase (CAT) mRNA levels but had no effects on mRNA levels of glutathione peroxidase (GPX) and the pro-inflammatory cytokine interleukin-6. There were no differences in plasma activity of the antioxidant enzymes GPX and CAT between all treatment groups. Our findings demonstrate some positive effects of watermelon for modulating lipids and attenuating lumbar vertebral bone loss arising from ovarian hormone deficiency.

Identifiants

pubmed: 32292754
doi: 10.3746/pnf.2020.25.1.41
pii: PNFS-25-041
pmc: PMC7143016
doi:

Types de publication

Journal Article

Langues

eng

Pagination

41-49

Informations de copyright

Copyright © 2020 by The Korean Society of Food Science and Nutrition. All rights Reserved.

Déclaration de conflit d'intérêts

AUTHOR DISCLOSURE STATEMENT The authors declare no conflict of interest.

Références

Cytokine Growth Factor Rev. 2004 Feb;15(1):49-60
pubmed: 14746813
J Nutr. 1993 Nov;123(11):1939-51
pubmed: 8229312
J Bone Miner Res. 2009 Jun;24(6):1086-94
pubmed: 19138129
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Pharmacol Res. 2010 Mar;61(3):219-25
pubmed: 19914380
Menopause. 2005 Nov-Dec;12(6):755-62
pubmed: 16278620
Nutr Res. 2015 Mar;35(3):251-8
pubmed: 25631716
J Nutr Biochem. 2012 Jan;23(1):60-8
pubmed: 21414765
J Nutr Biochem. 2008 Oct;19(10):694-9
pubmed: 18328688
J Nutr. 2003 Jun;133(6):1892-7
pubmed: 12771335
J Bone Miner Res. 2014 Nov;29(11):2520-6
pubmed: 24771492
Osteoporos Int. 2011 Apr;22(4):1091-101
pubmed: 20552330
Nutr Res. 2018 Oct;58:46-54
pubmed: 30340814
Osteoporos Int. 2007 Jan;18(1):109-15
pubmed: 16941193
J Ethnopharmacol. 2004 May;92(1):93-101
pubmed: 15099854
Int J Endocrinol. 2013;2013:213234
pubmed: 23573086
Am J Med. 2003 Aug 15;115(3):209-16
pubmed: 12947959
Endocr Rev. 2010 Jun;31(3):266-300
pubmed: 20051526
Clin Interv Aging. 2010 Nov 19;5:345-54
pubmed: 21228900
Trends Endocrinol Metab. 2011 Apr;22(4):117-23
pubmed: 21353592
Cancer Lett. 1997 Nov 25;120(1):15-22
pubmed: 9570381
Calcif Tissue Int. 2014 Apr;94(4):442-53
pubmed: 24357047
J Clin Invest. 2003 Sep;112(6):915-23
pubmed: 12975476
Lancet. 2002 May 18;359(9319):1761-7
pubmed: 12049882
J Nutr Biochem. 2013 May;24(5):882-6
pubmed: 22902326
Physiol Behav. 2006 Jan 30;87(1):39-44
pubmed: 16181647
Am J Clin Nutr. 1999 Apr;69(4):727-36
pubmed: 10197575
Nutrients. 2016 Aug 22;8(8):
pubmed: 27556488
Am J Clin Nutr. 2003 Sep;78(3 Suppl):517S-520S
pubmed: 12936943
Endocrinology. 1998 Jun;139(6):2659-61
pubmed: 9607769
Endocrinology. 2005 Feb;146(2):728-35
pubmed: 15528306
Clin Ther. 2015 Aug;37(8):1837-50
pubmed: 26163201
J Am Coll Nutr. 2016 Aug;35(6):514-520
pubmed: 26934084
Atherosclerosis. 2004 Apr;173(2):223-9
pubmed: 15064095
Eur J Nutr. 2012 Sep;51(6):637-63
pubmed: 22684631

Auteurs

Edralin A Lucas (EA)

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

Maryam Yuhas (M)

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

Kayla White (K)

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

Penelope Perkins-Veazie (P)

Department of Horticultural Science, North Carolina State University Research Campus, Kannapolis, NC 28081, USA.

Maureen Beebe (M)

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

Sandra Peterson (S)

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

Mark E Payton (ME)

Department of Statistics, Oklahoma State University, Stillwater, OK 74075, USA.

Brenda J Smith (BJ)

Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA.

Classifications MeSH